SAMI: Determining the Role of Social Reward Learning in Social Anhedonia

Sponsor
University of Alabama at Birmingham (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05617898
Collaborator
University of California, Los Angeles (Other), National Institute of Mental Health (NIMH) (NIH)
152
2
2
55
76
1.4

Study Details

Study Description

Brief Summary

This is a clinical trial study that aims to evaluate the specificity of the relationship between reduced sensitivity to social reward and social anhedonia at both behavioral and neural levels. Individuals who recently experienced their first-episode psychosis will be recruited. Participants will be randomized 1:1 to motivational interviewing or a time- and format-matched control probe. At pre- and post-probe, participants will perform two social reward learning tasks in the scanner. With this design feature, we will examine the relationship between sensitivity to social reward and reduced subjective experience of social pleasure at both the behavioral and neural levels.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Motivational Interviewing
  • Behavioral: Nutrition Didactic Training
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
152 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Determining the Role of Social Reward Learning in Social Anhedonia in First-Episode Psychosis Using Motivational Interviewing in a Perturbation-Based Neuroimaging Approach
Anticipated Study Start Date :
Apr 1, 2023
Anticipated Primary Completion Date :
Nov 1, 2027
Anticipated Study Completion Date :
Nov 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Motivational Interview Intervention

This arm involves three 45-minute sessions on motivational interviewing targeting sensitivity to social reward.

Behavioral: Motivational Interviewing
Three motivational interviewing sessions will target sensitivity to social reward, including subjective evaluation of social interaction, socially rewarding stimuli, and events (e.g., interactions with others, feedback from others).

Active Comparator: Active Control Intervention

This arm involves three 45-minute sessions on didactic training on nutrition.

Behavioral: Nutrition Didactic Training
The Nutrition didactic training will ask participants to discuss pros and cons of healthy eating habits and how to improve their current eating habits.

Outcome Measures

Primary Outcome Measures

  1. Response Bias [3 weeks]

    Response bias is defined as the likelihood of making one response, such as the frequently rewarded stimulus, more than the other response during the perceptual social reward learning task

  2. the number of optimal response [3 weeks]

    The number of optimal response is defined as the number of responses choosing a stimuli with optimal outcomes (e.g., choosing a good over a neutral machine or choosing a neutral over a bad machine) during the inductive social reward learning task.

  3. fMRI activation levels [3 weeks]

    fMRI activation is defined as beta weights from general linear model from key regions of interests including the ventromedial prefrontal cortex, dorsal anterior cingulate cortex and ventral striatum during the perceptual social reward learning task and the inductive social reward learning task.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 35 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18-35 years

  • A first episode of a psychotic illness that began within the past two years

  • Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 diagnosis of schizophrenia, schizophreniform, or schizoaffective disorder (depressed type)

  • Taking 2nd generation antipsychotic medications

  • Estimated premorbid IQ not less than 70 as assessed with the Wechsler Test of Adult Reading

  • Appropriate for scanning (i.e., no pacemaker or metal implants) and expressed willingness to participate in scanning

  • Sufficient fluency in English to comprehend testing procedures

  • Corrected vision of at least 20/30

Exclusion Criteria:
  • No evidence that substance use makes the diagnosis ambiguous (rule out substance-induced psychosis)

  • No evidence of moderate or severe alcohol or substance use disorder in the past 3 months

  • No clinically significant disease based on medical history (e.g., epilepsy) or significant head injury

  • For females: no current pregnancy

  • No sedatives or anxiolytics on the day of assessment

  • No medication change 3 weeks prior to enrollment

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama at Birmingham Birmingham Alabama United States 35294
2 University of California Los Angeles Los Angeles California United States 90095

Sponsors and Collaborators

  • University of Alabama at Birmingham
  • University of California, Los Angeles
  • National Institute of Mental Health (NIMH)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Junghee Lee, Associate Professor, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT05617898
Other Study ID Numbers:
  • IRB-300009711
First Posted:
Nov 16, 2022
Last Update Posted:
Jan 25, 2023
Last Verified:
Jan 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Junghee Lee, Associate Professor, University of Alabama at Birmingham
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 25, 2023